• Revenue from ordinary activities up 28.4% to $124.8m
• Underlying profit before tax up 29.7% to $90.7m
• Reported net profit after tax up 230.9% to $171.2m

Pro Medicus Limited, a leading healthcare informatics company, today announced its interim results for the six months ended December 2025. The company reported a 28.4% increase in revenue from ordinary activities to $124.8 million, and a 29.7% increase in underlying profit before tax to $90.7 million. Reported net profit after tax was $171.2 million, up 230.9%, which includes unrealized gains of $149.1 million before tax from the company's $10 million hybrid debt and equity investment in 4D Medical Limited. Pro Medicus' cash and other financial assets at December 2025 were $221.8 million, an increase of 5.3% despite paying out increased dividends, two share buybacks, and the $10 million investment in 4D Medical. The company announced a fully franked interim dividend of 32 cents per share and remains debt-free. During the period, the company signed seven new contracts, including a 10-year $170 million contract with the University of Colorado, a 5-year $10 million contract with University Hospital Heidelberg, and a 5-year $44 million contract with Advanced Radiology Management. Pro Medicus CEO Dr. Sam Hupert said the company's profits continue to grow strongly, with margins also increasing, and the company making more sales in this half than it used to make in a full year just two years ago. The company plans to complete another seven go-lives before the end of the financial year, with revenues flowing as each implementation comes on stream.

Pro Medicus expects continued strong financial performance, with the company's pipeline remaining very strong across all market segments. The company has provided no specific forward-looking financial metrics.

Pro Medicus remains optimistic about its future prospects, with the company's one product and business model allowing it to address the full range of opportunities in the US diagnostic imaging market. The company believes it is unique in this regard and expects to see a continuation of the trends that drove its record interim results.